[Biological aspects of drug effects].
D000200:Action Potentials; D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D000470:Alkaloids / Q000494:pharmacology; D000818:Animals; D001646:Bile; D001693:Biological Transport, Active; D001775:Blood Circulation; D002118:Calcium / Q000378:metabolism; D002301:Cardiac Glycosides / Q000378:metabolism*; D002417:Cattle; D003472:Curare / Q000494:pharmacology; D004285:Dogs; D005243:Feces; D006321:Heart / Q000502:physiology*; D066298:In Vitro Techniques; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000201:enzymology; D009124:Muscle Proteins / Q000378:metabolism*; D009130:Muscle, Smooth / Q000502:physiology; D004364:Pharmaceutical Preparations / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D011485:Protein Binding; D012964:Sodium / Q000378:metabolism; D012995:Solubility; D013328:Strophanthins / Q000494:pharmacology*; D013874:Thiopental / Q000378:metabolism; D014117:Toxiferine / Q000378:metabolism / Q000494:pharmacology; D014556:Urine
D000470:Alkaloids; D002301:Cardiac Glycosides; D009124:Muscle Proteins; D004364:Pharmaceutical Preparations; D013328:Strophanthins; D003472:Curare; D014117:Toxiferine; D012964:Sodium; D000251:Adenosine Triphosphatases; D013874:Thiopental; D011188:Potassium; D002118:Calcium
Biologische Aspekte der Arzneimittelwirkung.